Abstract: The present invention relates to a method for predicting sensitivity to treatment with vascular endothelial growth factor receptor (VEGFR) inhibitors, by using a biomarker. An effective means and anticancer therapy for cancer treatment of liver cancer are selected by predicting the effect of treatment with VEGFR inhibitors on liver cancer patients through the present invention, thereby increasing the treatment effect and minimizing the side effects of liver cancer treatment.
Type:
Application
Filed:
October 22, 2015
Publication date:
February 1, 2018
Applicants:
CBSBIOSCIENCE INC., GIL MEDICAL CENTER
Inventors:
Jin Young Park, Young Ho Moon, Jung-Hee Kwon, Yun Soo Kim, Ju Hyun Kim, Duck Joo Choi